Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.

George T Kannarkat Stanley N Caroff James F Morley

Published in: Tremor and other hyperkinetic movements (New York, N.Y.) (2022)

Several novel antipsychotics, particularly lumateperone and pimavanserin, show promise in being able to treat psychosis while reducing the risk of DIMD. Long-acting paliperidone may reduce risk of DIMD while other long-acting injectable formulations of SGA have similar risk of DIMD compared to oral formulations. New drug targets for treating psychosis without dopamine blockade also show promise.

Keyphrases

drug induced
liver injury
big data
adverse drug
uric acid
emergency department
artificial intelligence